Wednesday, February 23, 2011
Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer
PurposeWe retrospectively evaluated the efficacy and safety of combination therapy of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer (MBC).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment